News

New round of financing led by Vensana Capital will support technology platform expansion and further validating VX1, Volta’s Artificial Intelligence (AI) Decision-Support Software in improving catheter ablation for complex cardiac...

FDA Fast-Track designation was granted to investigate abelacimab for the prevention of stroke and systemic embolism in patients with atrial fibrillation.

Diversifies Healthcare Talent Solutions with Addition of Leading Cardiovascular Specialty Staffing and Education Business Builds on Long-Term Growth Strategy December 22, 2022 04:05 PM Eastern Standard Time--GREENWOOD VILLAGE, Colo....

Broadens MedTech Portfolio with World Leading Solutions for Heart Recovery Strengthens Position in High-Growth MedTech Segments NEW BRUNSWICK, N.J. – December 22, 2022 – Johnson & Johnson today announced it has completed its...

The Consumer Technology Association (CTA) awards Abbott multiple CES 2023 Innovation Awards for industry-leading health technologies Abbott's Aveir™ single-chamber (VR) leadless pacemaker, Proclaim™ Plus SCS system, Alinity® m...

MINNEAPOLIS, Dec. 20, 2022--CVRx, Inc., a commercial-stage medical device company focused on developing, manufacturing, and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that...

St. Louis, Dec. 20, 2022 (GLOBE NEWSWIRE)–-Stereotaxis, the global leader in robotic technologies for the treatment of cardiac arrhythmias, today announced the successful treatment of patients using the latest Genesis Robotic Magnetic...

SOPHIA ANTIPOLIS (Dec 16, 2022) --The current model for randomized clinical trials must be redesigned for the 21st century, according to the European Society of Cardiology (ESC), American Heart Association (AHA), World Heart Federation...

Companies initiate research agreement supporting development of new AI-ECG algorithm to help identify patients who may be at risk of cardiac amyloidosis